ANROVSNRSN• 3 Months (Normalized)
ANRO vs NRSN (Alto Neuroscience Inc. vs NeuroSense Therapeutics Ltd.)
Showing Closing Date Range from Jun 30 to Sep 28, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANRO Performance $27.5
+4.21%
Alto Neuroscience Inc.
Normalized Baseline0.00%
NRSN Performance $7.4
+927.78%
NeuroSense Therapeutics Ltd.
Normalized Baseline0.00%
Alpha Spread Margin NRSN LEADS
-923.57 pts
NRSN outperforming by 923.57 percentage points
ANRONRSN
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANRO NRSN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(60 dates)
| Date | ANRO Price | ANRO Gain (%) | NRSN Price | NRSN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $27.50 | +4.21% | $7.40 | +927.78% | -923.57% |
| Sep 22, 2026 | $30.78 | +16.64% | $7.18 | +897.22% | -880.58% |
| Sep 21, 2026 | $30.63 | +16.07% | $6.62 | +819.44% | -803.37% |
| Sep 18, 2026 | $30.27 | +14.70% | $6.35 | +781.94% | -767.24% |
| Sep 17, 2026 | $30.98 | +17.39% | $6.72 | +833.33% | -815.94% |
| Sep 16, 2026 | $30.00 | +13.68% | $6.49 | +801.39% | -787.71% |
| Sep 15, 2026 | $30.25 | +14.63% | $7.03 | +876.39% | -861.76% |
| Sep 14, 2026 | $31.68 | +20.05% | $6.90 | +858.33% | -838.28% |
| Sep 11, 2026 | $32.00 | +21.26% | $0.35 | -51.81% | +73.07% |
| Sep 10, 2026 | $31.68 | +20.05% | $0.33 | -53.89% | +73.94% |
| Sep 09, 2026 | $34.07 | +29.10% | $0.40 | -44.31% | +73.41% |
| Sep 08, 2026 | $35.81 | +35.70% | $0.42 | -41.94% | +77.64% |
| Sep 04, 2026 | $35.55 | +34.71% | $0.51 | -29.03% | +63.74% |
| Sep 03, 2026 | $36.40 | +37.93% | $0.40 | -44.17% | +82.10% |
| Sep 02, 2026 | $36.64 | +38.84% | $0.41 | -42.92% | +81.76% |
Page 1 of 4